207 related articles for article (PubMed ID: 32244978)
1. Sexually Dimorphic Behavioral Profile in a Transgenic Model Enabling Targeted Recombination in Active Neurons in Response to Ketamine and (2R,6R)-Hydroxynorketamine Administration.
Herzog DP; Mellema RM; Remmers F; Lutz B; Müller MB; Treccani G
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32244978
[TBL] [Abstract][Full Text] [Related]
2. Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2
Fukumoto K; Fogaça MV; Liu RJ; Duman C; Kato T; Li XY; Duman RS
Proc Natl Acad Sci U S A; 2019 Jan; 116(1):297-302. PubMed ID: 30559184
[TBL] [Abstract][Full Text] [Related]
3. BDNF-TrkB signaling-mediated upregulation of Narp is involved in the antidepressant-like effects of (2R,6R)-hydroxynorketamine in a chronic restraint stress mouse model.
Ju L; Yang J; Zhu T; Liu P; Yang J
BMC Psychiatry; 2022 Mar; 22(1):182. PubMed ID: 35291971
[TBL] [Abstract][Full Text] [Related]
4. Brain-derived neurotrophic factor in the ventrolateral periaqueductal gray contributes to (2R,6R)-hydroxynorketamine-mediated actions.
Chou D
Neuropharmacology; 2020 Jun; 170():108068. PubMed ID: 32222405
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant-relevant concentrations of the ketamine metabolite (2
Lumsden EW; Troppoli TA; Myers SJ; Zanos P; Aracava Y; Kehr J; Lovett J; Kim S; Wang FH; Schmidt S; Jenne CE; Yuan P; Morris PJ; Thomas CJ; Zarate CA; Moaddel R; Traynelis SF; Pereira EFR; Thompson SM; Albuquerque EX; Gould TD
Proc Natl Acad Sci U S A; 2019 Mar; 116(11):5160-5169. PubMed ID: 30796190
[TBL] [Abstract][Full Text] [Related]
6. A Pharmacological Evaluation of the Analgesic Effect and Hippocampal Protein Modulation of the Ketamine Metabolite (2R,6R)-Hydroxynorketamine in Murine Pain Models.
Das V; Basovich MB; Thomas CJ; Kroin JS; Buvanendran A; McCarthy RJ
Anesth Analg; 2024 May; 138(5):1094-1106. PubMed ID: 37319016
[TBL] [Abstract][Full Text] [Related]
7. Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of (
Highland JN; Morris PJ; Zanos P; Lovett J; Ghosh S; Wang AQ; Zarate CA; Thomas CJ; Moaddel R; Gould TD
J Psychopharmacol; 2019 Jan; 33(1):12-24. PubMed ID: 30488740
[TBL] [Abstract][Full Text] [Related]
8. Sex-specific neurobiological actions of prophylactic (R,S)-ketamine, (2R,6R)-hydroxynorketamine, and (2S,6S)-hydroxynorketamine.
Chen BK; Luna VM; LaGamma CT; Xu X; Deng SX; Suckow RF; Cooper TB; Shah A; Brachman RA; Mendez-David I; David DJ; Gardier AM; Landry DW; Denny CA
Neuropsychopharmacology; 2020 Aug; 45(9):1545-1556. PubMed ID: 32417852
[TBL] [Abstract][Full Text] [Related]
9. (
Zanos P; Highland JN; Stewart BW; Georgiou P; Jenne CE; Lovett J; Morris PJ; Thomas CJ; Moaddel R; Zarate CA; Gould TD
Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6441-6450. PubMed ID: 30867285
[TBL] [Abstract][Full Text] [Related]
10. Ketamine metabolite (2R,6R)-hydroxynorketamine reverses behavioral despair produced by adolescent trauma.
Elmer GI; Tapocik JD; Mayo CL; Zanos P; Gould TD
Pharmacol Biochem Behav; 2020 Sep; 196():172973. PubMed ID: 32569786
[TBL] [Abstract][Full Text] [Related]
11. Sex-dependent metabolism of ketamine and (
Highland JN; Farmer CA; Zanos P; Lovett J; Zarate CA; Moaddel R; Gould TD
J Psychopharmacol; 2022 Feb; 36(2):170-182. PubMed ID: 34971525
[TBL] [Abstract][Full Text] [Related]
12. cAMP-dependent protein kinase signaling is required for (
Riggs LM; Pereira EFR; Thompson SM; Gould TD
J Neurophysiol; 2024 Jan; 131(1):64-74. PubMed ID: 38050689
[TBL] [Abstract][Full Text] [Related]
13. (2R,6R)-hydroxynorketamine rescues chronic stress-induced depression-like behavior through its actions in the midbrain periaqueductal gray.
Chou D; Peng HY; Lin TB; Lai CY; Hsieh MC; Wen YC; Lee AS; Wang HH; Yang PS; Chen GD; Ho YC
Neuropharmacology; 2018 Sep; 139():1-12. PubMed ID: 29953886
[TBL] [Abstract][Full Text] [Related]
14. (S)-norketamine and (2S,6S)-hydroxynorketamine exert potent antidepressant-like effects in a chronic corticosterone-induced mouse model of depression.
Yokoyama R; Higuchi M; Tanabe W; Tsukada S; Naito M; Yamaguchi T; Chen L; Kasai A; Seiriki K; Nakazawa T; Nakagawa S; Hashimoto K; Hashimoto H; Ago Y
Pharmacol Biochem Behav; 2020 Apr; 191():172876. PubMed ID: 32088360
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological evaluation of clinically relevant concentrations of (2R,6R)-hydroxynorketamine.
Shaffer CL; Dutra JK; Tseng WC; Weber ML; Bogart LJ; Hales K; Pang J; Volfson D; Am Ende CW; Green ME; Buhl DL
Neuropharmacology; 2019 Jul; 153():73-81. PubMed ID: 31015046
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of the ketamine metabolite (2R,6R)-hydroxynorketamine in mice models of pain.
Kroin JS; Das V; Moric M; Buvanendran A
Reg Anesth Pain Med; 2019 Jan; 44(1):111-117. PubMed ID: 30640662
[TBL] [Abstract][Full Text] [Related]
17. (R)-Ketamine exerts antidepressant actions partly via conversion to (2R,6R)-hydroxynorketamine, while causing adverse effects at sub-anaesthetic doses.
Zanos P; Highland JN; Liu X; Troppoli TA; Georgiou P; Lovett J; Morris PJ; Stewart BW; Thomas CJ; Thompson SM; Moaddel R; Gould TD
Br J Pharmacol; 2019 Jul; 176(14):2573-2592. PubMed ID: 30941749
[TBL] [Abstract][Full Text] [Related]
18. Lack of metabolism in (R)-ketamine's antidepressant actions in a chronic social defeat stress model.
Zhang K; Fujita Y; Hashimoto K
Sci Rep; 2018 Mar; 8(1):4007. PubMed ID: 29507385
[TBL] [Abstract][Full Text] [Related]
19. Antinociceptive and Analgesic Effects of (2
Yost JG; Wulf HA; Browne CA; Lucki I
J Pharmacol Exp Ther; 2022 Sep; 382(3):256-265. PubMed ID: 35779947
[TBL] [Abstract][Full Text] [Related]
20. Effects of subanesthetic ketamine and (2R,6R) hydroxynorketamine on working memory and synaptic transmission in the nucleus reuniens in mice.
Goswamee P; Rice R; Leggett E; Zhang F; Manicka S; Porter JH; McQuiston AR
Neuropharmacology; 2022 May; 208():108965. PubMed ID: 35065945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
